Analysis: New Coloplast strategy could boost profit
There is huge growth potential for Denmark’s Coloplast in changing its distribution strategy, according to a memo from pan-Nordic bank Nordea.
BY STEFAN SINGH KAILAY
It might be difficult to see how Danish medtech group Coloplast could be able to raise its margins any higher but in a new 32-page memo, pan-Nordic bank Nordea points to a strategic choice that could singlehandedly boost the group’s operating result (EBIT) by up to 40% for the current fiscal year.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
These products will drive growth in Coloplast
For abonnenter
Bernstein: Two firms courting Coloplast rival
For abonnenter
